By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immune Design Corporation 

1102 Columbia Street
Suite 104
Seattle  Washington  98104  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
Immune Design Corporation (IMDZ) Added To Russell 2000® Index 10/2/2014 8:14:06 AM
Sanofi (France) (SAN.PA), Immune Design Corporation (IMDZ) Strike Food Allergy Deal Worth $168 Million+ 8/7/2014 9:08:46 AM
Immune Design Corporation (IMDZ) Announces Closing Of Initial Public Offering 7/30/2014 7:42:51 AM
Immune Design Corporation (IMDZ) Announces Filing Of New Lawsuit By Theravectys SA 7/28/2014 7:55:18 AM
THERAVECTYS Files Suit In The U.S. Against Immune Design Corporation (IMDZ) 7/25/2014 9:10:42 AM
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014 9:06:27 AM
Seattle's Immune Design Corporation (IMDZ) Files For $60 Million IPO 6/26/2014 4:00:44 PM
Immune Design Corporation Announces Treatment Of First Patient In Phase 1 Clinical Trial Of LV305 Immuno-Oncology Agent 6/5/2014 8:38:55 AM
Immune Design Corporation's GLAAS™ Discovery Platform Used In MEDI7510 Phase 1 Trial For Respiratory Syncytial Virus 5/27/2014 9:29:32 AM
Immune Design Corporation Appoints Franklin M. Berger To Board Of Directors 3/18/2014 6:34:05 AM